New MRI technique may spot aggressive rectal cancers before surgery
NCT ID NCT07269912
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether a special type of MRI, called IVIM-MRI, can predict lymphovascular invasion (LVI) in rectal cancer patients before surgery. LVI is a sign that the cancer may spread, and knowing this ahead of time could help doctors choose the best treatment. The study plans to enroll 400 participants and will follow them for two years to see if the MRI predictions match actual outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intravoxel incoherent motion magnetic resonance imaging (IVIM-MRI)
What this could lead to
If successful, this could provide a non-invasive way to predict which rectal cancers are more likely to spread, allowing doctors to tailor treatments more precisely.
What could go wrong
This is an early-stage study with 400 participants, and previous similar MRI methods have shown limited accuracy. The technique may not be reliable enough for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.